MedPath

ADIAL PHARMACEUTICALS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
$6.3M
Website

Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms

Phase 3
Completed
Conditions
Alcohol Use Disorder
Interventions
Drug: AD04 (ondansetron)
Drug: Matching placebo
Device: Companion Diagnostic for Genetic Testing
Behavioral: Brief Psychological Counseling
First Posted Date
2019-09-24
Last Posted Date
2024-04-17
Lead Sponsor
Adial Pharmaceuticals
Target Recruit Count
302
Registration Number
NCT04101227
Locations
🇧🇬

State Psychiatric Hospital, Kardzhali, Bulgaria

🇧🇬

State Psychiatric Hospital for Treatment of drug addiction and alcoholism, Sofia, Bulgaria

🇭🇷

Polyclinic Neuron, Zagreb, Croatia

and more 21 locations
© Copyright 2025. All Rights Reserved by MedPath